Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

Vice president and general manager of UK & Ireland at LEO Pharma, Sarah Kleinpeter, said: “We are pleased that adolescents between 12-17 years of age living with atopic dermatitis will now have ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

A recent survey conducted with online opinion panel LEO on behalf of the Regroupement des pharmacies de médicaments de spécialité (RPMSQ) reveals that Quebecers value that they have the ability to ...

The deal replaces a previous, $6 billion agreement that was rejected last July by the Supreme Court because it would have ...

Bio-Techne Corporation TECH is set to release its second-quarter fiscal 2025 results on Feb. 5, before the opening bell. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. The ...

Varadkar has been named as the Hauser Leader of the Harvard Kennedy School Center for Public Leadership for its spring ...